Skip to content
Clinical Trials – home
Azienda Ospedaliero Universitaria Di Modena
Sponsor

Azienda Ospedaliero Universitaria Di Modena

Italy Via Pietro Giardini 1355, 41126 Modena, Italy

About the sponsor

Research activity includes adult intensive care for patients requiring mechanical ventilation, with interest in oxygen management, respiratory support, and survival in critically ill populations. Additional work addresses septic shock and bacteremia, including treatment strategies for resistant bloodstream infections.

  • Mechanical ventilation
  • Septic shock
  • Bloodstream infections
  • Oxygen therapy

The sponsor also studies antimicrobial approaches in complicated urinary tract infections and infections caused by resistant Enterobacterales.

About Specializations

Azienda Ospedaliero Universitaria Di Modena runs clinical trials in conditions such as Bacteraemia, Preterm premature rupture of membranes, Assisted fertilisation, Septic shock, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

13 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Dinoprostone
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Lutropin Alfa
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Leuprorelin Acetate
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena

Septic shock

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Immunoglobulin A
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ertapenem Sodium
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Registered drug
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Fentanyl Citrate
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena

COVID-19

Not yet recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Metformin
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).